added img title

e6a47ab9 · Vesa Oikonen · 261ceb47 · e6a47ab9 · e6a47ab9 · e6a47ab9
Commit e6a47ab9 authored 2 months ago by Vesa Oikonen
--- a/content/acetate.html
+++ b/content/acetate.html
@@ -36,7 +36,7 @@ monocarboxylate transporter and <a href="./target_aquaporins.html">aquaporins</a
 across cell membranes.</p> 
 <p><a href="./pic/acetate-acetylCoA.svg"><img src="./pic/acetate-acetylCoA.svg" 
-  alt="acetate to acetyl-CoA conversion by ACH" 
+  alt="acetate to acetyl-CoA conversion by ACH" title="acetate to acetyl-CoA conversion by ACH" 
  style="padding:6px 0px 0px 6px; width:350px; float:right;" /></a>
 </p>
@@ -74,9 +74,9 @@ acetate (<a href="https://doi.org/10.1016/0969-8051(94)90178-3">Kihlberg et al.,
 <div class="images">
 <a href="./pic/1-11C-acetate.svg"><img src="./pic/1-11C-acetate.svg" height="80" 
- alt="[1-11C]Acetate" style="padding:0px 10px 0px 0px;" /></a>
+ alt="[1-11C]Acetate" title="[1-11C]Acetate" style="padding:0px 10px 0px 0px;" /></a>
 <a href="./pic/2-11C-acetate.svg"><img src="./pic/2-11C-acetate.svg" height="80" 
- alt="[2-11C]Acetate" style="padding:0px 10px 0px 0px;" /></a>
+ alt="[2-11C]Acetate" title="[2-11C]Acetate" style="padding:0px 10px 0px 0px;" /></a>
 <p>[1-<sup>11</sup>C]Acetate and [2-<sup>11</sup>C]acetate, labelled into C-1 and C-2 position, 
 respectively.</p> 
 </div>
@@ -116,7 +116,8 @@ of astrocytic metabolism in the brain
 <h2><a name="18F"><sup>18</sup>F-labelled acetate</a></h2>
 <p><a href="./pic/18F-fluoroacetate.svg"><img src="./pic/18F-fluoroacetate.svg" 
-  alt="18F-fluoroacetate" style="padding:6px 0px 0px 6px; width:100px; float:right;" /></a>
+  alt="18F-fluoroacetate" title="18F-fluoroacetate" 
+  style="padding:6px 0px 0px 6px; width:100px; float:right;" /></a>
 </p>
 <p>The hydrogen atoms of the methyl group can be replaced with <sup>18</sup>F to produce
@@ -163,22 +164,6 @@ it with ethanol to increase lipophilicity. The resulting proradiotracer [<sup>18
 the brain rapidly and was converted to TCA cycle metabolites
 (<a href="https://doi.org/10.1016/j.nucmedbio.2008.11.006">Mori et al., 2009</a>).</p>
-<!-- Moved into its own page
-<p><a href="./pic/2-18F-fluoropropionate.svg"><img src="./pic/2-18F-fluoropropionate.svg" 
-  alt="18F-labelled propionate" style="padding:6px 0px 0px 6px; width:100px; float:right;" /></a>
-</p>
-<h3><a name="FPA">2-[<sup>18</sup>F]fluoropropionate</a></h3>
-<p>2-[<sup>18</sup>F]fluoropropionate is another SCFA radiopharmaceutical that mimics acetate, 
-and could be used in tumour imaging because of increased fatty acid synthesis
-(<a href="https://doi.org/10.2967/jnumed.109.064212">Pillarsetty et al., 2009</a>;
-<a href="https://doi.org/10.1177/1536012118821032">Zhao et al., 2019</a>;
-Zhang et al., <a href="https://doi.org/10.1007/s11307-019-01346-1">2019</a> and
-<a href="https://doi.org/10.1007/s11307-021-01608-x">2021</a>).</p>
-->
 <br>
 <h2>See also:</h2>

--- a/content/analysis_11c-pbr28.html
+++ b/content/analysis_11c-pbr28.html
@@ -12,7 +12,7 @@ tags:
 <h1>Quantification of [<sup>11</sup>C]PBR28 PET studies</h1>
-<p><a href="./pic/11C-PBR28.svg"><img src="./pic/11C-PBR28.svg" alt="11C-PBR28" 
+<p><a href="./pic/11C-PBR28.svg"><img src="./pic/11C-PBR28.svg" alt="11C-PBR28" title="11C-PBR28" 
  style="padding:10px 0px 0px 10px; width:150px; float:right;" /></a>
 </p>

--- a/content/analysis_11c-pib.html
+++ b/content/analysis_11c-pib.html
@@ -13,7 +13,7 @@ tags:
 <h1>Analysis of [<sup>11</sup>C]PIB PET data</h1>
 <div>
-<p><a href="./pic/11C-PIB.svg"><img src="./pic/11C-PIB.svg" alt="11C-PIB" 
+<p><a href="./pic/11C-PIB.svg"><img src="./pic/11C-PIB.svg" alt="11C-PIB" title="11C-PIB" 
  style="padding:10px 0px 0px 10px; width:200px; float:right;" /></a>
 </p>

--- a/content/analysis_11c-pk11195.html
+++ b/content/analysis_11c-pk11195.html
@@ -14,7 +14,7 @@ tags:
 <div>
-<p><a href="./pic/11C-PK11195.svg"><img src="./pic/11C-PK11195.svg" alt="11C-PK11195" 
+<p><a href="./pic/11C-PK11195.svg"><img src="./pic/11C-PK11195.svg" alt="11C-PK11195" title="11C-PK11195" 
  style="padding:10px 0px 0px 10px; width:150px; float:right;" /></a>
 </p>

--- a/content/analysis_11c-smw139.html
+++ b/content/analysis_11c-smw139.html
@@ -13,7 +13,7 @@ tags:
 <p><a href="./pic/11C-SMW139.svg">
-<img src="./pic/11C-SMW139.svg" alt="[C-11]SMW139" 
+<img src="./pic/11C-SMW139.svg" alt="[C-11]SMW139" title="[C-11]SMW139" 
     style="padding:10px 0px 0px 10px; width:200px; float:right;" />
 </a></p>

--- a/content/analysis_11c-ucb-j.html
+++ b/content/analysis_11c-ucb-j.html
@@ -13,7 +13,7 @@ tags:
 <p><a name="fig1"></a>
 <a href="./pic/(C-11)UCB-J.svg">
-<img src="./pic/(C-11)UCB-J.svg" alt="[C-11]UCB-J" 
+<img src="./pic/(C-11)UCB-J.svg" alt="[C-11]UCB-J" title="[C-11]UCB-J" 
     style="padding:10px 0px 0px 10px; width:180px; float:right;" />
 </a></p>

--- a/content/analysis_18f-ef5.html
+++ b/content/analysis_18f-ef5.html
@@ -7,7 +7,7 @@ tags:
  - Hypoxia
 ---
-<p><a href="./pic/18F-EF5.svg"><img src="./pic/18F-EF5.svg" alt="F-18 labelled EF5" 
+<p><a href="./pic/18F-EF5.svg"><img src="./pic/18F-EF5.svg" alt="F-18 labelled EF5" title="F-18 labelled EF5" 
     style="padding:10px 0px 0px 10px; width:180px; float:right;" /></a></p>
 <h1>[<sup>18</sup>F]EF5 PET</h1>

--- a/content/analysis_18f-fbpa.html
+++ b/content/analysis_18f-fbpa.html
@@ -33,9 +33,9 @@ The effective dose from [<sup>18</sup>F]FBPA PET study is similar than that of
 <figure style="border: 1px solid #000;">
  <a href="./pic/L-BPA.svg">
-  <img style="width:250px; margin: 0.5em;" src="./pic/L-BPA.svg" alt="L-BPA"></a>
+  <img style="width:250px; margin: 0.5em;" src="./pic/L-BPA.svg" alt="L-BPA" title="L-BPA"></a>
  <a href="./pic/(F-18)FBPA.svg">
-  <img style="width:250px; margin: 0.5em;" src="./pic/(F-18)FBPA.svg" alt="FBPA"></a>
+  <img style="width:250px; margin: 0.5em;" src="./pic/(F-18)FBPA.svg" alt="FBPA" title="FBPA"></a>
  <figcaption style="margin: 0.5em;"><strong>L-BPA and [<sup>18</sup>F]FBPA</strong> 
  </figcaption>
 </figure>
@@ -228,10 +228,6 @@ the <sup>10</sup>B in organs (normal tissues) by simply multiplying the relative
 [<sup>18</sup>F]FBPA per g tissue by the therapeutic dose (g) of L-BPA, neglecting possible
 saturation effects from the much higher mass of the L-BPA dose.</p>
-<--
-->
 <br>
 <h2>See also:</h2>

--- a/content/analysis_18f-fda.html
+++ b/content/analysis_18f-fda.html
@@ -17,9 +17,11 @@ tags:
 <figure style="border: 1px solid #000;">
  <a href="./pic/norepinephrine.svg">
-  <img style="width:220px; margin: 0.5em;" src="./pic/norepinephrine.svg" alt="Norepinephrine"></a>
+  <img style="width:220px; margin: 0.5em;" src="./pic/norepinephrine.svg"
+    alt="Norepinephrine" title="Norepinephrine"></a>
  <a href="./pic/6-18F-FDA.svg">
-  <img style="width:220px; margin: 0.5em;" src="./pic/6-18F-FDA.svg" alt="6-[F-18]-FDA"></a>
+  <img style="width:220px; margin: 0.5em;" src="./pic/6-18F-FDA.svg"
+    alt="6-[F-18]-FDA" title="6-[F-18]-FDA"></a>
  <figcaption style="margin: 0.5em;">Norepinephrine (noradrenaline) and 
    6-[<sup>18</sup>F]fluorodopamine (6-[<sup>18</sup>F]FDA)
  </figcaption>

--- a/content/analysis_18f-fdg.html
+++ b/content/analysis_18f-fdg.html
@@ -19,8 +19,8 @@ tags:
 <h1>Quantification of metabolic rate of glucose uptake with [<sup>18</sup>F]FDG</h1>
 <p><a href="./pic/(F-18)fdg.svg">
-<img src="./pic/(F-18)fdg.svg" alt="2-[F-18]fluoro-2-deoxy-D-glucose" 
+<img src="./pic/(F-18)fdg.svg" style="padding:10px 0px 0px 10px; width:200px; float:right;"
-     style="padding:10px 0px 0px 10px; width:200px; float:right;" />
+     alt="2-[F-18]fluoro-2-deoxy-D-glucose" title="2-[F-18]fluoro-2-deoxy-D-glucose" />
 </a></p>
 <p>[<sup>18</sup>F]2-fluoro-2-deoxy-D-glucose ([<sup>18</sup>F]FDG) is a <a href="./glucose.html"

--- a/content/analysis_18f-fdopa.html
+++ b/content/analysis_18f-fdopa.html
@@ -32,9 +32,9 @@ and [<sup>18</sup>F]FPDOPA
 <figure style="border: 1px solid #000;">
  <a href="./pic/L-DOPA.svg">
-  <img style="width:250px; margin: 0.5em;" src="./pic/L-DOPA.svg" alt="L-DOPA"></a>
+  <img style="width:250px; margin: 0.5em;" src="./pic/L-DOPA.svg" alt="L-DOPA" title="L-DOPA"></a>
  <a href="./pic/6-(F-18)FDOPA.svg">
-  <img style="width:250px; margin: 0.5em;" src="./pic/6-(F-18)FDOPA.svg" alt="FDOPA"></a>
+  <img style="width:250px; margin: 0.5em;" src="./pic/6-(F-18)FDOPA.svg" alt="FDOPA" title="FDOPA"></a>
  <figcaption style="margin: 0.5em;"><strong>L-DOPA and 6-[<sup>18</sup>F]FDOPA</strong> 
  </figcaption>
 </figure>

--- a/content/analysis_18f-fgln.html
+++ b/content/analysis_18f-fgln.html
@@ -12,7 +12,7 @@ tags:
 <h1>(2<em>S</em>,4<em>R</em>)-4-[<sup>18</sup>F]fluoroglutamine</h1>
 <div><a href="./pic/2S4R-4-18F-FGln.png"><img src="./pic/2S4R-4-18F-FGln.png" 
-     alt="(2S,4R)-4-[18F]fluoroglutamine" 
+     alt="(2S,4R)-4-[18F]fluoroglutamine" title="(2S,4R)-4-[18F]fluoroglutamine" 
     style="padding:10px 0px 0px 10px; width:200px; float:right;" /></a></div>
 <p><a href="./glutamine.html">L-Glutamine</a> (Gln) has many important functions in 

--- a/content/analysis_18f-fpa.html
+++ b/content/analysis_18f-fpa.html
@@ -13,7 +13,8 @@ tags:
 <p><a href="./pic/2-18F-fluoropropionate.svg"><img src="./pic/2-18F-fluoropropionate.svg" 
-  alt="18F-labelled propionate" style="padding:6px 0px 0px 6px; width:100px; float:right;" /></a>
+  alt="18F-labelled propionate" title="18F-labelled propionate" 
+  style="padding:6px 0px 0px 6px; width:100px; float:right;" /></a>
 </p>
 <p>2-[<sup>18</sup>F]fluoropropionate (2-[<sup>18</sup>F]fluoropropionic acid, [<sup>18</sup>F]FPA) 

--- a/content/analysis_18f-fpatpp.html
+++ b/content/analysis_18f-fpatpp.html
@@ -8,7 +8,7 @@ tags:
  - Cannabinoids
 ---
-<div><a href="./pic/18F-FPATPP.png"><img src="./pic/18F-FPATPP.png" alt="[18F]FPATPP" 
+<div><a href="./pic/18F-FPATPP.png"><img src="./pic/18F-FPATPP.png" alt="[18F]FPATPP" title="[18F]FPATPP" 
     style="padding:10px 0px 0px 10px; width:260px; float:right;" /></a></div>
 <h1>[<sup>18</sup>F]FPATPP PET</h1>

--- a/content/analysis_18f-fpia.html
+++ b/content/analysis_18f-fpia.html
@@ -11,7 +11,8 @@ tags:
 <h1>[<sup>18</sup>F]FPIA PET</h1>
 <p><a href="./pic/18F-FPIA.svg"><img src="./pic/18F-FPIA.svg" 
-  alt="18F-labelled pivalate" style="padding:6px 0px 0px 6px; width:100px; float:right;" /></a>
+  alt="18F-labelled pivalate" title="18F-labelled pivalate"
+  style="padding:6px 0px 0px 6px; width:100px; float:right;" /></a>
 </p>
 <p>[<sup>18</sup>F]Fluoro-pivalic acid ([<sup>18</sup>F]FPIA) is based on a non-natural 

--- a/content/analysis_18f-mfbg.html
+++ b/content/analysis_18f-mfbg.html
@@ -33,11 +33,14 @@ is safer, allows same-day imaging, and better image quality than what is possibl
 <figure style="border: 1px solid #000;">
  <a href="./pic/norepinephrine.svg">
-  <img style="width:160px; margin: 0.5em;" src="./pic/norepinephrine.svg" alt="Noradrenaline"></a>
+  <img style="width:160px; margin: 0.5em;" src="./pic/norepinephrine.svg"
+    alt="Noradrenaline" title="Noradrenaline"></a>
  <a href="./pic/123I-MIBG.svg">
-  <img style="width:200px; margin: 0.5em;" src="./pic/123I-MIBG.svg" alt="[I-123]MIBG"></a>
+  <img style="width:200px; margin: 0.5em;" src="./pic/123I-MIBG.svg"
+    alt="[I-123]MIBG" title="[I-123]MIBG"></a>
  <a href="./pic/18F-MFBG.svg">
-  <img style="width:200px; margin: 0.5em;" src="./pic/18F-MFBG.svg" alt="[F-18]MFBG"></a>
+  <img style="width:200px; margin: 0.5em;" src="./pic/18F-MFBG.svg" 
+    alt="[F-18]MFBG" title="[F-18]MFBG"></a>
  <figcaption style="margin: 0.5em;">Noradrenaline, [<sup>123</sup>I]MIBG, and [<sup>18</sup>F]MFBG
  </figcaption>
 </figure>

--- a/content/analysis_18f-psma-1007.html
+++ b/content/analysis_18f-psma-1007.html
@@ -9,7 +9,8 @@ tags:
 ---
-<div><a href="./pic/18F-PSMA-1007.svg"><img src="./pic/18F-PSMA-1007.svg" alt="[18F]PSMA-1007" 
+<div><a href="./pic/18F-PSMA-1007.svg"><img src="./pic/18F-PSMA-1007.svg"
+     alt="[18F]PSMA-1007" title="[18F]PSMA-1007" 
     style="padding:10px 0px 0px 10px; width:300px; float:right;" /></a></div>
@@ -117,7 +118,6 @@ was 0.05&plusmn;0.02 min<sup>-1</sup> in prostate cancer lesions;
 0.09&plusmn;0.08, 0.15&plusmn;0.08, and 0.04&plusmn;0.02 in bone metastases;
 median <em>k<sub>3</sub></em> was 35-fold higher than <em>k<sub>4</sub></em> in prostate cancer
 lesions (<a href="https://doi.org/10.1007/s00259-019-04569-0">Sachpekidis et al., 2020</a>).
 </p>
 <h3>Mass effect</h3>

--- a/content/bnct.html
+++ b/content/bnct.html
@@ -47,7 +47,7 @@ this highly useful technique. Accelerator-based neutron sources are being develo
 <div>
 <a href="./pic/L-BPA.svg">
-<img src="./pic/L-BPA.svg" alt="L-BPA" 
+<img src="./pic/L-BPA.svg" alt="L-BPA" title="L-BPA" 
     style="padding:8px 0px 0px 8px; width:180px; float:right;" /></a>
 <p>Numerous boron carriers have been developed and studied, and two, 

--- a/content/citrate.html
+++ b/content/citrate.html
@@ -10,7 +10,7 @@ tags:
 <p>
 <a href="./pic/citrate.svg">
-<img src="./pic/citrate.svg" alt="citrate ion" 
+<img src="./pic/citrate.svg" alt="citrate ion" title="citrate ion" 
     style="padding:10px 0px 0px 10px; width:180px; float:right;" />
 </a>
 </p>

--- a/content/glucose.html
+++ b/content/glucose.html
@@ -16,7 +16,7 @@ tags:
 <p>
 <a href="./pic/D-glucose.svg">
-<img src="./pic/D-glucose.svg" alt="D-Glucose" 
+<img src="./pic/D-glucose.svg" alt="D-Glucose" title="D-Glucose" 
     style="padding:10px 0px 0px 10px; width:200px; float:right;" />
 </a>
 </p>